Saturday | 30 August, 2008
Stories about: Cell Therapeutics
- +
BORIS, leukaemia and John Rasko 28/03/2008 15:50:38
The New Directions in Leukaemia Research Conference starts next week and will feature John Rasko and two zinc finger transcription factors called BORIS and CTCF. - +
Mesoblast gets ethical backing for stem cell trial 20/04/2005 15:09:55
Melbourne stem cell therapeutics developer Mesoblast (ASX:MSB) has received ethics approval to begin a Phase I human trial of its adult stem cell therapy for angina. - +
Mind your fingers as the IPO window closes 29/06/2004 15:30:16
Market analysts are wondering whether the windown for Australian biotech IPOs has slammed shut. - +
Trials without error: Australia's clinical capabilities 01/06/2004 15:33:28
The secret's out -- Australia is a great place to do clinical trials and contract research, as Renate Krelle discovers. - +
Living Cell Technologies issues prospectus for $7 million ASX listing 20/05/2004 15:22:28
Cell therapeutics company Living Cell Technologies has issued a prospectus to raise almost AUD$7 million through both a rights issue and a general issue. - +
Singapore's Cygenics issues prospectus for $18 million ASX float 06/05/2004 15:14:55
Singapore-based stem cell therapeutics company CyGenics has issued its prospectus for an AUD$18 million float on the ASX. With a pre-money valuation of $50 million, CyGenics will have a market capitalisation after the float of $68 million.
Additional Resources
Newsletter Subscription
Australian Life Scientist Member Login
Beyond The Hybrid TV Card Norm 2008-08-26 15:29:00+10
Go Green with Kingston - Save the PCB, Save the World 2008-08-25 16:10:00+10
VIA Pico-ITX at the Heart of Modern Robots 2008-08-25 13:50:00+10
Fujitsu unveils winning formula for success with Intel® Centrino® 2 processor technology. 2008-08-25 12:42:00+10
Multimedia Technology & Herma Technologies announce new audience feedback solution from REPLY Systems. 2008-08-19 11:05:00+10
Sponsored Links
Subscribe to Australian Life Scientist
Australian Life Scientist is Australia's leading magazine for the life sciences sector. ALS is available free of charge to qualified persons working in the life sciences - register now for your free subscription.
